Brief: Cumberland Pharmaceuticals Inc - Initiative Designed To Help Address Potential Antibiotic Shortages
23/03/2020 21:48
Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS ANNOUNCES INITIATIVE TO EXPAND
AVAILABILITY OF VIBATIV® TO TREAT HOSPITAL-ACQUIRED &
VENTILATOR-ASSOCIATED PNEUMONIA RESULTING FROM CORONAVIRUS
INFECTIONS
* CUMBERLAND PHARMACEUTICALS INC - INITIATIVE DESIGNED TO
HELP
ADDRESS POTENTIAL ANTIBIOTIC SHORTAGES
* CUMBERLAND PHARMACEUTICALS INC - RESPONSE TO COVID-19
CRISIS
INCLUDES SPECIAL SUPPLY ARRANGEMENTS FOR U.S. HOSPITALS
* CUMBERLAND PHARMA - FINANCIAL ARRANGEMENTS BEING OFFERED
BY
CUMBERLAND INCLUDE EXTENDED PAYMENT TERMS FOR DIRECT ACCOUNT
PURCHASES OF VIBATIV
Source text for Eikon: ID:nPn4sDZvca
Further company coverage: CPIX.O
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM